Signal Explorer

Fcpa Compliance Representation New York Jurisdiction Clause Ipo Net Proceeds Disclosure Corporate Organization And Standing Representation Nyse Listing Disclosure Use Of Proceeds Disclosure Sanctions Compliance Representation Market Price Definition Form S3 Shelf Registration Disclosure Corporate Authority Representation Conflicted Defense Counsel Provision No Regulatory Approval Required Closing Condition Opinions And Certificates Prospectus Supplement Disclosure

Indication Expansion

Clinical Trial Result Combination Therapy Mentioned Clinical Hold Lead Asset Progress

Interim Data Positive Patient Retention High Priority Review Or Pdufa Disclosed Publication Positive Fast Track Granted Safety Differentiated Fda Aligned Fast Track Designation Received

Clinical Hold Active

Rsu Psu Vesting Schedule Disclosed Transfer And Demand Rights Limitations Cash Flow Statement Investing Activities Financing Activities Cash Flow Disclosure Operating Lease Rent Expense Disclosed Fair Value Hierarchy Reconciliation Disclosed Share Withholding Tax Settlement Ipo Or Capital Raising Completion Net Loss Reported Other Income Expense Disclosure Equity Award Plan Types Enumerated Nonqualified Stock Option Exercise Or Grant Shares Outstanding Disclosure

Clinical Trial Result

Ai Drug Discovery Investment

Executive Educational Background Disclosure Net Loss Reported Patient Retention High Interim Data Positive Kol Endorsement Expanded Access Program Active Publication Positive Liquidity Position Snapshot Disclosed Fast Track Designation Received

Indication Expansion Clinical Trial Result Lead Asset Progress Combination Therapy Mentioned

Clinical Hold Active

Volume Inflecting

Cash Flow Statement Investing Activities Financing Activities Cash Flow Disclosure Fair Value Hierarchy Reconciliation Disclosed Operating Lease Rent Expense Disclosed Net Loss Reported Other Income Expense Disclosure Liquidity Position Snapshot Disclosed Ipo Net Proceeds Disclosure Shares Outstanding Disclosure Institutional Investment Interim Data Positive Nonqualified Stock Option Exercise Or Grant

Clinical Trial Result Indication Expansion Lead Asset Progress

Net Loss Reported Enrollment Ahead Of Schedule Patient Retention High Interim Data Positive Ipo Or Capital Raising Completion Kol Endorsement Expanded Access Program Active Safety Differentiated Publication Positive

Clinical Trial Result Indication Expansion Combination Therapy Mentioned Lead Asset Progress Clinical Hold

Clinical Hold Active

Executive Educational Background Disclosure Classified Board Director Election

Executive Educational Background Disclosure Employee Director Compensation Waiver Director Continuity Stated